Mette S. Janas

Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer

Agnes Lee, Pieter W. Kamphuisen, Guy Meyer et al. · JAMA · 2015 · 603 citations · Full text

O-242 Gefitinib (‘Iressa’, ZD1839) monotherapy for pretreated advanced non-small-cell lung cancer in IDEAL 1 and 2: tumor response is not clinically relevantly predictable from tumor EGFR membrane staining alone

Renee Bailey, Mark G. Kris, Michael Wolf et al. · Lung Cancer · 2003 · 96 citations

Tumor Response, O-242 Gefitinib, Medicine +9

CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients

Agnes Lee, Rupert Bauersachs, Mette S. Janas et al. · BMC Cancer · 2013 · 74 citations · Full text

Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial

Alok A. Khorana, Pieter W. Kamphuisen, Guy Meyer et al. · Journal of Clinical Oncology · 2017 · 71 citations

Biomarker Analyses, Catch Trial, Recurrent Vte +24

Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism—Analysis of the CATCH Study

Agnes Lee, Pieter W. Kamphuisen, Guy Meyer et al. · Thrombosis and Haemostasis · 2018 · 50 citations